Literature DB >> 28875355

Is there an association between flow diverter fish mouthing and delayed-type hypersensitivity to metals?-a case-control study.

Naci Kocer1, Prabath Kumar Mondel2, Elif Yamac2, Ayse Kavak3, Osman Kizilkilic2, Civan Islak2.   

Abstract

PURPOSE: Flow diverters are increasingly used in the treatment of complex and giant intracranial aneurysms. However, they are associated with complications like late aneurysmal rupture. Additionally, flow diverters show focal structural decrease in luminal diameter without any intimal hyperplasia. This resembles a "fish mouth" when viewed en face. In this pilot study, we tested the hypothesis of a possible association between flow diverter fish-mouthing and delayed-type hypersensitivity to its metal constituents.
METHODS: We retrospectively reviewed patient records from our center between May 2010 and November 2015. A total of nine patients had flow diverter fish mouthing. A control group of 25 patients was selected. All study participants underwent prospective patch test to detect hypersensitivity to flow diverter metal constituents. Analysis was performed using logistic regression analysis and Wilcoxon sign rank sum test. Univariate and multivariate analyses were performed to test variables to predict flow diverter fish mouthing.
RESULTS: The association between flow diverter fish mouthing and positive patch test was not statistically significant. In multivariate analysis, history of allergy and maximum aneurysm size category was associated with flow diverter fish mouthing. This was further confirmed on Wilcoxon sign rank sum test.
CONCLUSION: The study showed statistically significant association between flow diverter fish mouthing and history of contact allergy and a small aneurysmal size. Further large-scale studies are needed to detect a statistically significant association between flow diverter fish mouthing and patch test. We recommend early and more frequent follow-up imaging in patients with contact allergy to detect flow diverter fish mouthing and its subsequent evolution.

Entities:  

Keywords:  Contact allergy; Delayed-type hypersensitivity; Fish mouthing; Flow diverter; In-stent stenosis; Patch test

Mesh:

Substances:

Year:  2017        PMID: 28875355     DOI: 10.1007/s00234-017-1910-3

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  28 in total

1.  Sensitivity, specificity and positive predictive value of patch testing: the more you test, the more you get? ESCD Working Party on Epidemiology.

Authors:  T L Diepgen; P J Coenraads
Journal:  Contact Dermatitis       Date:  2000-06       Impact factor: 6.600

2.  Delayed ipsilateral parenchymal hemorrhage following flow diversion for the treatment of anterior circulation aneurysms.

Authors:  J P Cruz; M Chow; C O'Kelly; B Marotta; J Spears; W Montanera; D Fiorella; T Marotta
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-08       Impact factor: 3.825

3.  Long-term results of enterprise stent-assisted coiling of cerebral aneurysms.

Authors:  Kyle M Fargen; Brian L Hoh; Babu G Welch; G Lee Pride; Giuseppe Lanzino; Alan S Boulos; Jeffrey S Carpenter; Ansaar Rai; Erol Veznedaroglu; Andrew Ringer; Rafael Rodriguez-Mercado; Peter Kan; Adnan Siddiqui; Elad I Levy; J Mocco
Journal:  Neurosurgery       Date:  2012-08       Impact factor: 4.654

4.  In vitro reproduction of device deformation leading to thrombotic complications and failure of flow diversion.

Authors:  Laurent Estrade; Alina Makoyeva; Tim E Darsaut; Jimmy Ghostine; Evgueni Kouznetsov; Igor Salazkin; Daniel Roy; Alain Weill; Jean Raymond
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

5.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

Review 6.  A Practical Guide to Patch Testing.

Authors:  Luz Fonacier
Journal:  J Allergy Clin Immunol Pract       Date:  2015-06-06

7.  Very late thrombosis of flow-diverting constructs after the treatment of large fusiform posterior circulation aneurysms.

Authors:  J Klisch; A Turk; R Turner; H H Woo; D Fiorella
Journal:  AJNR Am J Neuroradiol       Date:  2011-03-24       Impact factor: 3.825

8.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

9.  Effect of structural remodeling (retraction and recoil) of the pipeline embolization device on aneurysm occlusion rate.

Authors:  L-D Jou; B D Mitchell; H M Shaltoni; M E Mawad
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-10       Impact factor: 3.825

10.  Focal, transient mechanical narrowing of a pipeline embolization device following treatment of an internal carotid artery aneurysm.

Authors:  Timothy Ryan Miller; Gaurav Jindal; Dheeraj Gandhi
Journal:  J Neurointerv Surg       Date:  2014-10-03       Impact factor: 5.836

View more
  3 in total

1.  Two- to five-year follow-up of 78 patients after treatment with the Flow Redirection Endoluminal Device.

Authors:  Hannes Luecking; Arnd Doerfler; Philipp Goelitz; Philip Hoelter; Tobias Engelhorn; Stefan Lang
Journal:  Interv Neuroradiol       Date:  2019-10-09       Impact factor: 1.610

2.  Pipeline Flex embolisation device with Shield Technology for the treatment of patients with intracranial aneurysms: periprocedural and 6 month outcomes.

Authors:  James Yeomans; Lilian Sandu; Anand Sastry
Journal:  Neuroradiol J       Date:  2020-10-22

3.  Delayed Stroke after Aneurysm Treatment with Flow Diverters in Small Cerebral Vessels: A Potentially Critical Complication Caused by Subacute Vasospasm.

Authors:  Stefan Schob; Cindy Richter; Cordula Scherlach; Dirk Lindner; Uwe Planitzer; Gordian Hamerla; Svitlana Ziganshyna; Robert Werdehausen; Manuel Florian Struck; Bernd Schob; Khaled Gaber; Jürgen Meixensberger; Karl-Titus Hoffmann; Ulf Quäschling
Journal:  J Clin Med       Date:  2019-10-10       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.